| Opportunity ID: | 334360 | | Opportunity Number: | RFA-DP-22-002 | | Opportunity Title: | Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts | | Opportunity Category: | Discretionary | | Opportunity Category Explanation: | | | Funding Instrument Type: | Cooperative Agreement | | Category of Funding Activity: | Health | | Category Explanation: | | | CFDA Number(s): | 93.283 | | Eligible Applicants: | State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” | | Additional Information on Eligibility: | This NOFO is open competition | | Agency Code: | HHS-CDC-HHSCDCERA | | Agency Name: | Department of Health and Human Services
Centers for Disease Control and Prevention – ERA | | Posted Date: | Jun 28, 2021 | | Last Updated Date: | Jun 28, 2021 | | Estimated Synopsis Post Date: | Nov 05, 2021 | | Fiscal Year: | 2022 | | Award Ceiling: | $900,000 | | Award Floor: | $870,000 | | Estimated Total Program Funding: | $22,000,000 | | Expected Number of Awards: | 5 | | Description: | The primary purpose of this opportunity is to fund applicants with existing access to adult lupus patient populations and can extend current knowledge over 12-17 years from baseline. A second component of this funding opportunity will focus on the pediatric lupus – to advance existing knowledge of lupus in pediatric populations using an existing cohort of lupus patients. Because lupus is a rare condition, it is efficient to obtain new information from existing relevant cohorts with lupus. The research objectives among both adult and pediatric populations are to: Examine the treatment (e.g., medications including opioid; type; appropriateness; etc.) of people with lupus. Determine health care access and gaps that people with lupus experience in addressing their varied health problems (e.g., general health problems as well as those for specific lupus outcomes, such as nephritis; transitions to adulthood). Determine longer term natural history (severity, chronic pain, progression, morbidity, mortality, disability and quality of life, work/ school/activity interference, etc.) of people with lupus, including assessing potential genetic factors. Examine other factors related to disparities in lupus outcomes (e.g., age, sex, and race/ethnic group). Examine lupus comorbidities. | | Version: | 1 |
|
